Detalhe da pesquisa
1.
Endocrinology/Primary Care Pharmacy Collaboration vs Endocrinology Care Alone in Patients With Type 2 Diabetes and A1c >9.
J Pharm Technol
; 40(2): 78-84, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38525094
2.
iGlarLixi versus premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: The SoliComplex real-world study.
Diabetes Obes Metab
; 25(5): 1249-1260, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36633506
3.
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study.
Diabetes Obes Metab
; 25(10): 2989-2998, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37402696
4.
Association of Metformin, Dipeptidyl Dipeptidase-4 Inhibitors, and Insulin with Coronavirus Disease 2019-Related Hospital Outcomes in Patients with Type 2 Diabetes.
Endocr Pract
; 29(9): 681-685, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37301375
5.
Initiation of iGlarLixi Versus Basal-Bolus Insulin in Adults With Type 2 Diabetes Advancing From Basal Insulin Therapy: The SoliComplex Real-World Study.
Diabetes Spectr
; 36(3): 253-263, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37583559
6.
Erratum: Addressing Therapeutic Inertia: Development and Implementation of an Electronic Health Record-Based Diabetes Intensification Tool. Diabetes Spectrum 2023;36:161-170 (https://doi.org/10.2337/ds22-0031).
Diabetes Spectr
; 36(4): 408, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38024221
7.
Addressing Therapeutic Inertia: Development and Implementation of an Electronic Health Record-Based Diabetes Intensification Tool.
Diabetes Spectr
; 36(2): 161-170, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37193209
8.
A model-based simulation of glycaemic control and body weight when switching from semaglutide to 3.0- and 4.5-mg doses of once-weekly dulaglutide.
Diabetes Obes Metab
; 24(2): 302-311, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34697882
9.
Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: An adjusted indirect treatment comparison.
Diabetes Obes Metab
; 24(9): 1861-1868, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35589616
10.
Association of obesity with postacute sequelae of COVID-19.
Diabetes Obes Metab
; 23(9): 2183-2188, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34060194
11.
Strategies for overcoming therapeutic inertia in type 2 diabetes: A systematic review and meta-analysis.
Diabetes Obes Metab
; 23(9): 2137-2154, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34180129
12.
Associations of weight loss with obesity-related comorbidities in a large integrated health system.
Diabetes Obes Metab
; 23(12): 2804-2813, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34472680
13.
Development and Internal Validation of A Prediction Tool To Assist Clinicians Selecting Second-Line Therapy Following Metformin Monotherapy For Type 2 Diabetes.
Endocr Pract
; 27(4): 334-341, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33685669
14.
RESULTS OF A 24-WEEK TRIAL OF TECHNOSPHERE INSULIN VERSUS INSULIN ASPART IN TYPE 2 DIABETES.
Endocr Pract
; 27(1): 38-43, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33471730
15.
When to Suspect Hidden Hypercortisolism in Type 2 Diabetes: A Meta-Analysis.
Endocr Pract
; 27(12): 1216-1224, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34325041
16.
Cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists: A comparison of study designs, populations and results.
Diabetes Obes Metab
; 22(12): 2209-2226, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32744372
17.
Relative contribution of basal and postprandial hyperglycaemia stratified by HbA1c categories before and after treatment intensification with dulaglutide.
Diabetes Obes Metab
; 21(6): 1365-1372, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30756511
18.
Low Rates of Screening for Hypercortisolism Among Patients With Severe Insulin Resistance Requiring U-500 Insulin.
Endocr Pract
; 30(5): 479-480, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38354951
19.
THE BENEFIT OF SHORT-TERM WEIGHT LOSS WITH ANTI-OBESITY MEDICATIONS IN REAL-WORLD CLINICAL PRACTICE.
Endocr Pract
; 25(10): 1022-1028, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31241358
20.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
Endocr Pract
; 25(11): 1191-1232, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31760824